Literature DB >> 8897272

Characterization of dihydrates prepared from carbamazepine polymorphs.

L E McMahon1, P Timmins, A C Williams, P York.   

Abstract

To clarify earlier literature suggesting its existence in more than one solid form, carbamazepine dihydrate was prepared from individual anhydrous carbamazepine polymorphs I and III. The resultant materials were characterized by thermal and spectroscopic techniques, including variable-temperature Fourier transform (FT) Raman spectroscopy. On thermal dehydration, the carbamazepine dihydrates formed different anhydrous polymorphs depending on both starting material and dehydration conditions. Under conditions where liberated hydrate water cannot readily escape from around the sample, the dihydrate originating from polymorph III reverted to polymorph III, but under conditions of lower humidity/moisture, this dihydrate reverted to polymorph I. The dihydrate originating from polymorph I reverted to polymorph I irrespective of dehydration conditions. These observations could be due to a trace amount of nonhydrated original polymorph existing in the dihydrate phase that acts as a seed to regenerate the original polymorph under conditions where liberated hydrate water cannot readily escape from around the sample during dehydration. No evidence was generated that supported the existence of true polymorphs of carbamazepine dihydrate.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8897272     DOI: 10.1021/js960117e

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  10 in total

1.  Dehydration kinetics and crystal water dynamics of carbamazepine dihydrate.

Authors:  K Kachrimanis; U J Griesser
Journal:  Pharm Res       Date:  2012-04       Impact factor: 4.200

2.  Mechanically induced amorphization of drugs: a study of the thermal behavior of cryomilled compounds.

Authors:  Niraj S Trasi; Stephen R Byrn
Journal:  AAPS PharmSciTech       Date:  2012-05-15       Impact factor: 3.246

3.  Classification of the crystallization behavior of amorphous active pharmaceutical ingredients in aqueous environments.

Authors:  Bernard Van Eerdenbrugh; Shweta Raina; Yi-Ling Hsieh; Patrick Augustijns; Lynne S Taylor
Journal:  Pharm Res       Date:  2013-11-23       Impact factor: 4.200

4.  Anion-switchable supramolecular gels for controlling pharmaceutical crystal growth.

Authors:  Jonathan A Foster; Marc-Oliver M Piepenbrock; Gareth O Lloyd; Nigel Clarke; Judith A K Howard; Jonathan W Steed
Journal:  Nat Chem       Date:  2010-10-10       Impact factor: 24.427

5.  Particle size dependent molecular rearrangements during the dehydration of trehalose dihydrate in situ FT-Raman spectroscopy.

Authors:  L S Taylor; A C Williams; P York
Journal:  Pharm Res       Date:  1998-08       Impact factor: 4.200

6.  Solid-vapor interactions: influence of environmental conditions on the dehydration of carbamazepine dihydrate.

Authors:  Rahul Surana; Abira Pyne; Raj Suryanarayanan
Journal:  AAPS PharmSciTech       Date:  2004-12-31       Impact factor: 3.246

7.  Quality of antiepileptic drugs in sub-Saharan Africa: A study in Gabon, Kenya, and Madagascar.

Authors:  Jeremy Jost; Voa Ratsimbazafy; Thu Trang Nguyen; Thuy Linh Nguyen; Hanh Dufat; Annabelle Dugay; Alassane Ba; Guilhem Sivadier; Yattussia Mafilaza; Cyril Jousse; Mounir Traïkia; Martin Leremboure; Emilie Auditeau; Adeline Raharivelo; Edgard Ngoungou; Symon M Kariuki; Charles R Newton; Pierre-Marie Preux
Journal:  Epilepsia       Date:  2018-06-12       Impact factor: 5.864

8.  Miniaturized assay for solubility and residual solid screening (SORESOS) in early drug development.

Authors:  Nicole Wyttenbach; Jochem Alsenz; Olaf Grassmann
Journal:  Pharm Res       Date:  2007-03-20       Impact factor: 4.580

9.  Influence of Carbamazepine Dihydrate on the Preparation of Amorphous Solid Dispersions by Hot Melt Extrusion.

Authors:  Xiangyu Ma; Felix Müller; Siyuan Huang; Michael Lowinger; Xu Liu; Rebecca Schooler; Robert O Williams Iii
Journal:  Pharmaceutics       Date:  2020-04-20       Impact factor: 6.321

10.  Recrystallization of commercial carbamazepine samples-a strategy to control dissolution variability.

Authors:  Felicia Flicker; Veronika A Eberle; Gabriele Betz
Journal:  Pharmaceutics       Date:  2012-01-13       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.